N-of-One

About:

N-Of-One analyzes and interprets tumor molecular profiles to help physicians and patients identify diagnostic and treatment strategies.

Website: http://n-of-one.com

Twitter/X: nofone

Top Investors: Excel Venture Management, Providence Ventures, CB Health Ventures, CVP Management

Description:

N-of-One Therapeutics provides cancer care services. Its team of clinicians and scientists works with a network of diagnostic laboratories, research institutions, and cancer experts to provide access to cancer research, medical science, and molecular diagnostic testing. The company conducts research to assess the standard of care and other diagnostic and treatment opportunities for various cancer types.

Total Funding Amount:

$12.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2008-01-01

Founders:

Jennifer Levin Carter

Number of Employees:

51-100

Last Funding Date:

2016-07-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai